7.28
price up icon4.15%   0.29
after-market アフターアワーズ: 7.14 -0.14 -1.92%
loading
前日終値:
$6.99
開ける:
$6.95
24時間の取引高:
1.07M
Relative Volume:
0.86
時価総額:
$395.14M
収益:
$1.02B
当期純損益:
$-757.20M
株価収益率:
-0.4932
EPS:
-14.76
ネットキャッシュフロー:
$-257.90M
1週間 パフォーマンス:
-0.68%
1か月 パフォーマンス:
+17.04%
6か月 パフォーマンス:
-26.32%
1年 パフォーマンス:
-39.43%
1日の値動き範囲:
Value
$6.95
$7.31
1週間の範囲:
Value
$6.74
$7.65
52週間の値動き範囲:
Value
$4.02
$15.10

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
名前
Emergent Biosolutions Inc
Name
セクター
Healthcare (1170)
Name
電話
240-631-3200
Name
住所
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
職員
900
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
EBS's Discussions on Twitter

EBS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
7.28 397.86M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
150.03 70.46B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.74 47.78B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.59 45.15B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.31 19.16B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.33 13.56B 2.99B 1.21B 1.13B 25.06

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-30 開始されました H.C. Wainwright Buy
2024-08-22 開始されました Rodman & Renshaw Buy
2024-03-07 アップグレード The Benchmark Company Hold → Buy
2023-11-20 再開されました JP Morgan Underweight
2023-08-29 ダウングレード The Benchmark Company Buy → Hold
2023-04-10 アップグレード The Benchmark Company Hold → Buy
2023-03-17 ダウングレード JP Morgan Neutral → Underweight
2022-11-10 ダウングレード The Benchmark Company Buy → Hold
2022-04-29 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-01-20 アップグレード The Benchmark Company Hold → Buy
2021-11-08 ダウングレード The Benchmark Company Buy → Hold
2021-05-05 ダウングレード Argus Buy → Hold
2021-04-07 開始されました The Benchmark Company Buy
2021-02-24 アップグレード Chardan Capital Markets Neutral → Buy
2021-02-19 ダウングレード Chardan Capital Markets Buy → Neutral
2021-01-08 ダウングレード Wells Fargo Overweight → Equal Weight
2020-09-14 再開されました JP Morgan Neutral
2020-07-31 繰り返されました Chardan Capital Markets Buy
2019-09-12 開始されました Guggenheim Buy
2019-09-04 アップグレード Wells Fargo Market Perform → Outperform
2018-11-02 アップグレード Goldman Neutral → Buy
2018-08-03 繰り返されました Chardan Capital Markets Buy
2018-06-13 開始されました Argus Buy
2018-04-25 ダウングレード Wells Fargo Outperform → Market Perform
2018-01-24 開始されました Goldman Neutral
2018-01-16 繰り返されました Chardan Capital Markets Buy
2016-06-28 繰り返されました Singular Research Buy
2016-04-15 開始されました Chardan Capital Markets Buy
2016-03-28 開始されました Singular Research Buy
2016-02-19 開始されました Wells Fargo Outperform
2014-05-15 開始されました Summer Street Research Buy
2011-05-31 繰り返されました WBB Securities Strong Buy
2011-01-10 繰り返されました Wedbush Outperform
2010-11-05 繰り返されました Wedbush Outperform
2010-08-18 アップグレード WBB Securities Buy → Strong Buy
2010-08-06 繰り返されました Caris & Company Buy
すべてを表示

Emergent Biosolutions Inc (EBS) 最新ニュース

pulisher
12:37 PM

Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate - TipRanks

12:37 PM
pulisher
04:59 AM

What makes Emergent BioSolutions Inc. stock price move sharplyPotential Rocket List - beatles.ru

04:59 AM
pulisher
Jul 16, 2025

Lobbying Update: $440,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Nasdaq

Jul 16, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions to Report Second Quarter 2025 Financial Re - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions Inc. to Host Q2 2025 Financial Results Conference Call on August 6 - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions Q2 2025 Earnings Call Scheduled for August 6: Key Details Inside - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 - TradingView

Jul 15, 2025
pulisher
Jul 14, 2025

Government Contract Update: $52M payment to EMERGENT BIOSOLUTIONS CANADA INC - Nasdaq

Jul 14, 2025
pulisher
Jul 10, 2025

Emergent BioSolutions signs contract modification award for CNJ-016 - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛

Jul 10, 2025
pulisher
Jul 09, 2025

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts - The Manila Times

Jul 09, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Stock Rises After New US Order For Smallpox Complication Therapy - Stocktwits

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions secures contract modification for smallpox treatment By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions secures contract modification for smallpox treatment - Investing.com Australia

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions (EBS) Expands Smallpox Vaccine Contract wi - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions (EBS) Secures Smallpox Preparedness Contra - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Gets $51.9 Million Contract Modification for Smallpox Preparedness - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions stock rises on government contract modification By Investing.com - Investing.com Canada

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions stock rises on government contract modification - Investing.com

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Secures Contract Modification for Additional VIGIV Doses to Support U.S. Smallpox Preparedness - Quiver Quantitative

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Strengthens US Biodefense Arsenal with $51.9M Government Contract - Stock Titan

Jul 08, 2025
pulisher
Jul 08, 2025

Emergent BioSolutions Secures $51.9 Million Contract Modificatio - GuruFocus

Jul 08, 2025
pulisher
Jul 07, 2025

Lobbying Update: $40,000 of EMERGENT BIOSOLUTIONS lobbying was just disclosed - Quiver Quantitative

Jul 07, 2025
pulisher
Jul 05, 2025

Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - simplywall.st

Jul 05, 2025
pulisher
Jul 03, 2025

Emergent BioSolutions adds KLOXXADO to online naloxone platform By Investing.com - Investing.com India

Jul 03, 2025
pulisher
Jul 02, 2025

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® ( - GuruFocus

Jul 02, 2025
pulisher
Jun 30, 2025

Investors Can Still File Late Claims in Emergent BioSolutions Settlement - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

Emergent BioSolutions Inc.(NYSE: EBS) added to Russell 2500 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 25, 2025

Is Emergent BioSolutions, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Emergent BioSolutions secures $62.4 million contract for botulism antitoxin By Investing.com - Investing.com South Africa

Jun 24, 2025
pulisher
Jun 20, 2025

Emergent BioSolutions to join Russell 3000 Index after market close June 27 - Investing.com

Jun 20, 2025
pulisher
Jun 19, 2025

EBS Stock Up 1.4% after 1-Day Win Streak - Trefis

Jun 19, 2025
pulisher
Jun 18, 2025

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030 - GlobeNewswire

Jun 18, 2025
pulisher
Jun 16, 2025

Government Contract Update: $62M payment to EMERGENT BIOSOLUTIONS CANADA INC - Nasdaq

Jun 16, 2025
pulisher
Jun 12, 2025

BRIEF—LigaChem links up with NovaRock - The Pharma Letter

Jun 12, 2025
pulisher
Jun 07, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO’s Insider Sales - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions at Jefferies Conference: Strategic Transformation By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Squarepoint Ops LLC Has $451,000 Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions (EBS) Partners with Foundation for Opioid Awareness | EBS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation's Nat - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies | EBS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Breaking: Dramatic 34% Drop in US Opioid Deaths as Emergent Expands Life-Saving Naloxone Access - Stock Titan

Jun 05, 2025
pulisher
Jun 03, 2025

Vaccine Contract Manufacturing Market Set to Witness - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Biodefense Market Set to Witness Significant GrowthEmergent BioSolutions Inc., SIGA Technologies - openPR.com

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Boosts Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Northern Trust Corp Acquires 3,692 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

May 28, 2025
pulisher
May 26, 2025

Emergent BioSolutions discloses CEO stock purchase - MSN

May 26, 2025
pulisher
May 23, 2025

Emergent Biosolutions Settlement Receives Preliminary Approval - TipRanks

May 23, 2025
pulisher
May 21, 2025

Emergent BioSolutions at RBC Conference: Strategic Turnaround Focus By Investing.com - Investing.com India

May 21, 2025
pulisher
May 19, 2025

Emergent BioSolutions ($EBS) Is Paying a $40M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 19, 2025

Emergent Biosolutions Inc (EBS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.60
price down icon 1.09%
$14.96
price up icon 3.10%
$9.27
price up icon 2.09%
drug_manufacturers_specialty_generic RDY
$14.69
price up icon 0.55%
$134.11
price up icon 0.47%
$297.33
price down icon 0.28%
大文字化:     |  ボリューム (24 時間):